- 全部删除
- 您的购物车当前为空
EP1013 is a broad-spectrum selective inhibitor of Caspase used in the study of type 1 diabetes.
EP1013 is a broad-spectrum selective inhibitor of Caspase used in the study of type 1 diabetes.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 6,320 | 8-10周 | |
50 mg | ¥ 8,210 | 8-10周 | |
100 mg | ¥ 13,200 | 8-10周 |
EP1013 相关产品
产品描述 | EP1013 is a broad-spectrum selective inhibitor of Caspase used in the study of type 1 diabetes. |
体内活性 | EP1013 therapy enhances functional syngeneic islet mass and promotes longevity of islet graft function.EP1013 (1, 3, 10 mg/kg) significantly improves marginal islet mass function. Two animals in the 10 mg/kg EP1013 treatment group exhibit primary islet graft nonfunction, but the diabetes reversal rate for this group is not significantly different from the 3 mg/kg EP1013, 1 mg/kg EP1013, or 10 mg/kg zVAD groups. |
别名 | F1013 |
分子量 | 382.38 |
分子式 | C18H23FN2O6 |
CAS No. | 223568-55-6 |
密度 | 1.258 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 60 mg/mL (156.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容